Evidence map›Paper›PMID 41078745›Full record

ReviewACS omega2025

Computational Methods in Immunoinformatics: Epitope Discovery and Diagnostic Applications.

Ana Carolina Silva Bulla, Alessandra Sbano da Silva, Bruno Prado Sereno, Maria Fernanda Ribeiro Dias, Manuela Leal da Silva

Abstract readReview
In one paragraph

Review in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ana Carolina Silva BullaPrograma de Pós-Graduação em Biologia Computacional e Sistemas, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Avenida Brasil 4365, Manguinhos, Rio de Janeiro, RJ 21040-900, Brazil.ORCID https://orcid.org/0000-0003-4118-294X
Alessandra Sbano da SilvaPrograma de Pós-Graduação em Biotecnologia, Instituto Nacional de Metrologia, Qualidade e Tecnologia, Av. Nossa Sra. das Graças 50, Xerém, Duque de Caxias, RJ 25250-020, Brazil.ORCID https://orcid.org/0000-0003-3912-5997
Bruno Prado SerenoPrograma de Pós-Graduação em Biologia Computacional e Sistemas, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Avenida Brasil 4365, Manguinhos, Rio de Janeiro, RJ 21040-900, Brazil.ORCID https://orcid.org/0009-0008-3723-4405
Maria Fernanda Ribeiro DiasPrograma de Pós-graduação Multicêntrico em Ciências Fisiológicas, Instituto de Biodiversidade e Sustentabilidade NUPEM/UFRJ, Universidade Federal do Rio de Janeiro, Avenida Amaro Reinaldo dos Santos Silva, 764. São José do Barreto, Macaé, RJ 27965-045, Brazil.ORCID https://orcid.org/0000-0002-0069-3199
Manuela Leal da SilvaPrograma de Pós-Graduação em Biologia Computacional e Sistemas, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Avenida Brasil 4365, Manguinhos, Rio de Janeiro, RJ 21040-900, Brazil.ORCID https://orcid.org/0000-0003-4844-7138

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review proposes a structured immunoinformatics framework tailored for diagnostic applications, addressing the current gap in standardized pipelines compared to well-established workflows in reverse vaccinology. Immunoinformatics integrates experimental immunology with computational approaches to predict antigen-epitope recognition by B and T cell immune receptors, supporting the identification of diagnostic and therapeutic targets. It enables rapid and cost-efficient prediction of peptide-MHC binding affinity and epitope immunogenicity through machine learning models and specialized algorithms trained on curated immunological data sets. Although epitope prediction pipelines are well-established in vaccinology, standardized frameworks for their application in diagnostic assays remain underdeveloped. This gap reflects challenges in integrating and implementing prediction tools within diagnostic development protocols, which demand distinct validation criteria and clinical applicability compared to vaccine design. We examine key methodological developments, and practical applications are illustrated through case studies involving viral, bacterial, parasitic, and fungal pathogens. Drawing from this assessment, we outline a modular pipeline for epitope prioritization that integrates sequence analysis, structural modeling, consensus-based prediction, and validation strategies. Analysis of the current literature suggests that prediction algorithms utilizing artificial intelligence models yield high accuracy in epitope identification. Following experimental validation, this approach demonstrates considerable potential for implementation in diagnostics. This integrative strategy underscores the value of combining AI-driven prediction, structural modeling, and multiepitope design in translational diagnostics. Epitope-centric approaches promise significant advances in biomarker platforms for diagnostics, vaccine development, and therapeutic design. This review highlights the integrative value of widely adopted immunoinformatics tools and their applicability to serological diagnostics.

Identifiers

PMID41078745
PMCPMC12508925

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.